Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia
about
Somatic STAT3 mutations in large granular lymphocytic leukemiaLarge granular lymphocytic leukemia. Current diagnostic and therapeutic approaches and novel treatment options.Emergence of a STAT3 mutated NK clone in LGL leukemia.Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.The pathogenesis and treatment of large granular lymphocyte leukemiaPlatelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway.A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia.Dynamical and structural analysis of a T cell survival network identifies novel candidate therapeutic targets for large granular lymphocyte leukemia.MICA polymorphism identified by whole genome array associated with NKG2D-mediated cytotoxicity in T-cell large granular lymphocyte leukemiaHow I treat LGL leukemia.Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemia.Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemiaTipifarnib-mediated suppression of T-bet-dependent signaling pathways.Effects of Toll-like receptor signals in T-cell neoplasms.Good syndrome presenting with CD8⁺ T-Cell large granular lymphocyte leukemiaMolecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes.Network model of survival signaling in large granular lymphocyte leukemia.T/B and not T/B: high frequency of B-cell dyscrasias in T-LGL leukemia.Regulation of Fas-mediated immune homeostasis by an activation-induced protein, Cyclon.Lack of common TCRA and TCRB clonotypes in CD8(+)/TCRαβ(+) T-cell large granular lymphocyte leukemia: a review on the role of antigenic selection in the immunopathogenesis of CD8(+) T-LGLThe root of many evils: indolent large granular lymphocyte leukaemia and associated disorders.Never say die: survival signaling in large granular lymphocyte leukemia.Large granular lymphocytic leukaemia pathogenesis and management.Pathophysiologic mechanisms and management of neutropenia associated with large granular lymphocytic leukemia.FLIP: molecular switch between apoptosis and necroptosis.Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations.Are T-LGL Leukemia and NK-Chronic Lymphoproliferative Disorder really two distinct diseases?Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches.Long-term safety and efficacy of cyclosporin A therapy for T-cell large granular lymphocyte leukemia.TRAIL mediates and sustains constitutive NF-κB activation in LGL leukemia.Familial CD3+T large granular lymphocyte leukemia: evidence that genetic predisposition and antigen selection promote clonal cytotoxic T-cell responses
P2860
Q27851792-C9907664-E58F-44A2-AC5D-BAA840843C2EQ30238757-36F94185-6885-487B-8B38-95CEC2C0F188Q30300601-2EDF3B0D-B2B3-4645-AE16-BAC47F38BB91Q30303110-AC09DBDA-E819-4E93-8CDE-F4BBF7A62B51Q30303161-0B4CD16A-C16A-4B3F-B868-33BE2E6D7F5FQ30405429-110A0574-128B-4657-84F4-EC43DCD8F781Q33579520-B2E97228-DC12-48A2-BEAA-FCE3ECE8CC9FQ33624229-86018E04-8DF0-418E-97A0-03AE04233C53Q34079139-41982309-BCF6-4AD4-8156-C5296C0B3091Q34166559-957095D4-88FC-4519-9A87-EA553F5AB50DQ34707130-6855AF41-BCC4-43CD-A6FE-03D462923084Q35136867-BDF0B158-93EA-4517-870A-BB3C7FF12C31Q35485805-556300E3-ABE5-4709-BF6E-90527C11C1CEQ36181770-46A76FC2-D12F-4CC0-BD9E-7F079CC6746AQ36293678-518ED332-865F-4C21-809A-D1410CC385ACQ36546727-035ACA06-6388-4933-A3F9-EB8471E59FC3Q36787581-D65DC7F4-D76D-4C9E-811C-EE410AD4B5A2Q36945148-EB6537EE-4196-4B3A-8E8C-AE8471039772Q37157430-0E69A574-7BE9-4337-9D62-47F502337DC9Q37306636-169905B6-812C-4A3E-AD3B-933E8A975F39Q37555303-F38A3A3E-8137-492F-9FE0-B3BB314A6FB3Q37567637-D70EFC9B-15E8-442D-A3A7-70DDD3122834Q37602880-3826F120-157E-4F7D-B915-32709EF1874FQ37821049-D7ABF69B-D260-4BB3-8EF8-96758B093106Q37888717-05DDEF5B-CD91-413C-B0B9-49B2FC99B862Q38102627-AD4A653F-AF6A-40E6-BC4D-0616D60547ACQ38186800-09FB29CE-749A-4D66-8431-351FE9689F47Q38978884-2156C2AF-52EE-4E65-A5F7-D7C818180939Q42574009-60313EA6-EA34-476B-BAB3-1D2EEA0C0DADQ43206364-ECB4657F-9B19-4BEE-8F8A-026A379C7CE7Q52716419-B5A0C7EB-7737-4345-8FB1-01C75380DB6EQ58041539-3A2A96AF-0513-49D1-AD2C-DAD2CF47268C
P2860
Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Antigen activation and impaire ...... e-granular lymphocyte leukemia
@ast
Antigen activation and impaire ...... e-granular lymphocyte leukemia
@en
type
label
Antigen activation and impaire ...... e-granular lymphocyte leukemia
@ast
Antigen activation and impaire ...... e-granular lymphocyte leukemia
@en
prefLabel
Antigen activation and impaire ...... e-granular lymphocyte leukemia
@ast
Antigen activation and impaire ...... e-granular lymphocyte leukemia
@en
P2093
P2860
P1433
P1476
Antigen activation and impaire ...... e-granular lymphocyte leukemia
@en
P2093
Jeffrey S Painter
Jianxiang Zou
P K Epling-Burnette
Thomas P Loughran
P2860
P304
P356
10.1182/BLOOD-2007-06-093823
P407
P577
2007-11-09T00:00:00Z